Health Insurance Coverage Protection Commission - Study on Individual and Group Health Insurance Market Stability
HB1112 expands the duties of the Maryland Health Insurance Coverage Protection Commission. The bill requires the Commission to study and make recommendations on ways to improve individual and group health insurance market stability in Maryland. Its required areas of study include actuarial comparisons of Medicaid and commercial rates, possible public option savings, alternative payment models for Medicaid, regulatory changes for managed care organizations, merging the individual and small group markets, interstate pooling of purchasing power, prescription drug cost controls, support for federally qualified health centers, a multi-year reinsurance fund, reinstating the Maryland Health Insurance Plan, pooling public purchasers, and increasing premium assistance in the individual market.
The bill is primarily a study-and-recommendation measure rather than a direct regulatory overhaul. It amends the 2025 law creating the Commission by adding a new subsection that broadens the Commission’s mandate, and it is tied to the existing sunset structure of that commission law. If enacted, it would guide future policy development by directing the Commission to evaluate multiple market-stabilization strategies and report on whether legislative or administrative changes are needed.
HB1112 does not itself change insurance coverage rules, rates, or benefits, but it does alter the statutory duties of the Maryland Health Insurance Coverage Protection Commission in Chapter 696 of the Acts of 2025. The bill requires the Commission to conduct a broader policy review of individual and group market stability and to consider a range of potential reforms affecting insurers, managed care organizations, Medicaid financing, prescription drug purchasing, reinsurance, premium subsidies, and public insurance options. Its practical effect is to shape future legislative and administrative action by generating recommendations and analysis for the General Assembly and state agencies.
The bill appears to have been received favorably overall. It passed the House unanimously on third reading, 128-0, and the committee report was favorable with amendments, suggesting broad support for continued study of health insurance market stability. The available record does not show recorded opposition in the House vote, and the bill advanced to the Senate for hearing.
Because the bill is a study commission expansion, the main points of potential contention are policy direction rather than immediate legal change. The listed topics include several debated health policy options, such as a public option, altering Medicaid payment structures, allowing managed care organizations into the individual market with reduced capital requirements, merging the individual and small group markets, interstate pooling, a state pharmacy benefit administrator, reinstating the Maryland Health Insurance Plan, and creating a reinsurance fund. These issues could draw differing views from insurers, consumer advocates, health care providers, and policymakers, especially where the bill asks the Commission to evaluate reforms that could affect premiums, market competition, and state spending.